semaglutide and eating disorders - latest news, breaking stories comment GLP-1s and eating disorders: What

This is considered an off-label use, and while early reports suggest the combination can enhance weight loss, clinical trials are limited

Gastrointestinal Effects The peptide significantly delays gastric emptying through actions on the gastric smooth muscle and vagal afferents, which slows nutrient absorption and helps regulate postprandial glucose excursions

The most common long-term issue is muscle and bone-density loss with rapid weight loss, which is why resistance training and adequate protein are emphasised

Developing sustainable eating patterns and exercise habits during treatment creates a foundation for weight maintenance